1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60:277–300.
2. Yip D, Harper PG. Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer. 2000;28:173–85.
3. Batus M, Myint R, Coon J, Basu S, Kaiser K, Fidler M, Bonomi P. N-cadherin, E-cadherin, ERCC1, and c-kit expression in small cell lung cancer (SCLC) and potential for new therapeutic targets. J Clin Oncol. 2009; 27(Suppl 15s):(abstract e22157).
4. Cañadas I, Arumi M, Lema L, Martinez A, Grande E, Bellosillo B, Rojo F, Rovira A, Albanell J, Arriola E. MET in small cell lung carcinoma (SCLC): effects of a MET inhibitor in SCLC cell lines and prognostic role of MET status in patients. J Clin Oncol. 2009; 27 (Suppl 15s):(abstract e14617).
5. Gonzalez R, Silva JM, Sanchez A, Dominguez G, Garcia JM, Chen XQ, Stroun M, Provencio M, España P, Anker P, Bonilla F. Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance. Ann Oncol. 2000;11:1097–104.